Topics

Takeda's Ninlaro shows progression-free survival benefit in multiple myeloma http://bit.ly/34EGX40  #pharmapic.twitter.com/F4N2RDL7Ys

05:41 EST 8 Nov 2019 | Pharmafile

Takeda's Ninlaro shows progression-free survival benefit in multiple myeloma http://bit.ly/34EGX40 

Original Article: Takeda's Ninlaro shows progression-free survival benefit in multiple myeloma http://bit.ly/34EGX40  #pharmapic.twitter.com/F4N2RDL7Ys

NEXT ARTICLE

More From BioPortfolio on "Takeda's Ninlaro shows progression-free survival benefit in multiple myeloma http://bit.ly/34EGX40  #pharmapic.twitter.com/F4N2RDL7Ys"

Quick Search